VKORC1 Gene and Bleeding Risk
Author Information
Author(s): Frits Rosendaal, Pieter H Reitsma
Hypothesis
The C1173T dimorphism in the VKORC1 gene affects coumarin sensitivity and bleeding risk.
Conclusion
The odds ratios for bleeding risk associated with the VKORC1 variant are close to the relative risk estimates, indicating a trivial difference.
Supporting Evidence
- The odds ratio is a good estimator of relative risk when the disease is rare.
- The study illustrates the relationship between odds ratios and relative risks using a hypothetical cohort.
- Estimates suggest that the odds ratios for bleeding risk are within 2% of the relative risk.
Takeaway
This study looks at how a specific gene affects the risk of bleeding when taking certain medications, finding that the gene's impact is small.
Methodology
The study discusses the use of odds ratios in case-control studies and compares them to relative risks in cohort studies.
Potential Biases
Potential bias due to the case-control design which limits the estimation of absolute risks.
Limitations
The study cannot calculate absolute risks from the case-control data due to the sampling method.
Participant Demographics
The study involves a cohort of 10,000 individuals, with a breakdown of those with and without the VKORC1 trait.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website